Zota Health Care has received registration licenses for two products from the Ministry of Health Department of Food and Drug Administration, Myanmar. The company has received registration licenses for LANZOCID-30 (Each hard gelatin capsule contains: Lansoprazole USP 30mg (as enteric coated pellets) and S-AMLOZED 2.5 (Each uncoated tablet contains: S-Amlodipine Besilate eq. to S-Amlodipine 2.5mg).
The company has received said product registration licenses for the validity period of five years; further the same can be renewed after expiration. The company shall commence export of these products in Myanmar in a near term.
Zota Health Care manufactures and markets pharmaceutical formulations, nutraceutical, and ayurvedic medicines in India and internationally.
| Company Name | CMP |
|---|---|
| Redington | 220.95 |
| Adani Enterprises | 2088.20 |
| Amrapali Industries | 17.32 |
| Rashi Peripheral | 404.30 |
| PDS | 295.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: